Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
The Journal of Experimental Medicine|April 25, 2023
SLE is not a one-size-fits-all diseaseMichael R Ehrenstein, Muhammad ShipaAnnals of Internal Medicine|October 26, 2021
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled TrialMuhammad Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, et al.The Lancet. Rheumatology|February 9, 2023
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trialMuhammad Shipa, Liliana R Santos, Dao X Nguyen, et al.Mediterranean Journal of Rheumatology|May 30, 2020
CNS Vasculitis in Anti-Synthetase SyndromeMuhammad Shipa, Maria Di Cicco, Euthalia RoussouThe Journal of Experimental Medicine|September 26, 2007
If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicineMichael R Ehrenstein, Claudia MauriArthritis Research & Therapy|March 14, 2007
Cells of the synovium in rheumatoid arthritis. B cellsClaudia Mauri, Michael R EhrensteinTrends in Immunology|February 22, 2008
The 'short' history of regulatory B cellsClaudia Mauri, Michael R EhrensteinNature Reviews. Rheumatology|February 19, 2016
The BAFFling effects of rituximab in lupus: danger ahead?Michael R Ehrenstein, Charlotte WingJournal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Cutting edge: selection of B lymphocyte subsets is regulated by natural IgMNicole Baker, Michael R EhrensteinFEBS Letters|August 11, 2011
Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritisKonstantia-Maria Chavele, Michael R EhrensteinPageof 7